BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 7910219)

  • 1. P-glycoprotein, HER-2/neu, and mutant p53 expression in human gynecologic tumors.
    Schneider J; Rubio MP; Barbazán MJ; Rodriguez-Escudero FJ; Seizinger BR; Castresana JS
    J Natl Cancer Inst; 1994 Jun; 86(11):850-5. PubMed ID: 7910219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of LRP and MDR1 in locally advanced breast cancer predicts axillary node invasion at the time of rescue mastectomy after induction chemotherapy.
    Schneider J; Gonzalez-Roces S; Pollán M; Lucas R; Tejerina A; Martin M; Alba A
    Breast Cancer Res; 2001; 3(3):183-91. PubMed ID: 11305953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a distinctive P-glycoprotein-mediated resistance phenotype in human ovarian carcinoma cells after their in vitro exposure to fractionated X-irradiation.
    Hill BT; Whelan RD; Hurst HC; McClean S
    Cancer; 1994 Jun; 73(12):2990-9. PubMed ID: 7911070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of resistance factors (P-glycoprotein, glutathione S-transferase-pi, and topoisomerase II) and their interrelationship to proto-oncogene products in renal cell carcinomas.
    Volm M; Kästel M; Mattern J; Efferth T
    Cancer; 1993 Jun; 71(12):3981-7. PubMed ID: 8099529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between polymorphisms of XRCC1, p53 and MDR1 genes, the expression of their protein products and prognostic significance in human breast cancer.
    Rybárová S; Vecanová J; Hodorová I; Mihalik J; Čižmáriková M; Mojžiš J; Solár P; Benický M; Adamkov M; Mirossay L
    Med Sci Monit; 2011 Dec; 17(12):BR354-63. PubMed ID: 22129893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative immunocytochemical assays of P-glycoprotein in breast carcinomas: correlation to messenger RNA expression and to immunohistochemical prognostic indicators.
    Charpin C; Vielh P; Duffaud F; Devictor B; Andrac L; Lavaut MN; Allasia C; Horschowski N; Piana L
    J Natl Cancer Inst; 1994 Oct; 86(20):1539-45. PubMed ID: 7932810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of P-glycoprotein overexpression and cellular prognostic factors in formalin-fixed, paraffin-embedded tumor samples from breast cancer patients.
    Schneider J; Romero H
    Anticancer Res; 1995; 15(3):1117-21. PubMed ID: 7645934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the HER-2/neu oncogene in gynecologic cancers.
    Cirisano FD; Karlan BY
    J Soc Gynecol Investig; 1996; 3(3):99-105. PubMed ID: 8796816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P53 overexpression predicts endometrial carcinoma recurrence better than HER-2/neu overexpression.
    Coronado PJ; Vidart JA; Lopez-asenjo JA; Fasero M; Furio-bacete V; Magrina J; Escudero M
    Eur J Obstet Gynecol Reprod Biol; 2001 Sep; 98(1):103-8. PubMed ID: 11516808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P-glycoprotein and tumor progression.
    Benchimol S; Ling V
    J Natl Cancer Inst; 1994 Jun; 86(11):814-6. PubMed ID: 7910218
    [No Abstract]   [Full Text] [Related]  

  • 11. p53 protein accumulation and gene mutation in the progression of human prostate carcinoma.
    Navone NM; Troncoso P; Pisters LL; Goodrow TL; Palmer JL; Nichols WW; von Eschenbach AC; Conti CJ
    J Natl Cancer Inst; 1993 Oct; 85(20):1657-69. PubMed ID: 7692074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical correlates of MDR1 (P-glycoprotein) gene expression in ovarian and small-cell lung carcinomas.
    Holzmayer TA; Hilsenbeck S; Von Hoff DD; Roninson IB
    J Natl Cancer Inst; 1992 Oct; 84(19):1486-91. PubMed ID: 1359152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of P-glycoprotein expression on sensitivity to hormones in MCF-7 human breast cancer cells.
    Clarke R; Currier S; Kaplan O; Lovelace E; Boulay V; Gottesman MM; Dickson RB
    J Natl Cancer Inst; 1992 Oct; 84(19):1506-12. PubMed ID: 1359153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients.
    Isola J; Visakorpi T; Holli K; Kallioniemi OP
    J Natl Cancer Inst; 1992 Jul; 84(14):1109-14. PubMed ID: 1352359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 and P-glycoprotein are often co-expressed and are associated with poor prognosis in breast cancer.
    Linn SC; Honkoop AH; Hoekman K; van der Valk P; Pinedo HM; Giaccone G
    Br J Cancer; 1996 Jul; 74(1):63-8. PubMed ID: 8679460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations of K-ras, p53, and erbB-2/neu in human lung adenocarcinomas.
    Bongiorno PF; Whyte RI; Lesser EJ; Moore JH; Orringer MB; Beer DG
    J Thorac Cardiovasc Surg; 1994 Feb; 107(2):590-5. PubMed ID: 7905543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 protein and c-erbB-2 protein (p185) expression in endometrial adenocarcinoma of endometrioid type. An immunohistochemical examination on paraffin sections.
    Nielsen AL; Nyholm HC
    Am J Clin Pathol; 1994 Jul; 102(1):76-9. PubMed ID: 7913577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of p53 mutations by means of single strand conformation polymorphism analysis in gynaecological tumours: comparison with the results of immunohistochemistry.
    Schneider J; Rubio MP; Rodriguez-Escudero FJ; Seizinger BR; Castresana JS
    Eur J Cancer; 1994; 30A(4):504-8. PubMed ID: 8018409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical analysis of p53 and HER-2/neu proteins in human tumors.
    Chang K; Ding I; Kern FG; Willingham MC
    J Histochem Cytochem; 1991 Sep; 39(9):1281-7. PubMed ID: 1680897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
    Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.